FAQ: Annovis Bio's Presentation at H.C. Wainwright Global Investment Conference

What is the main announcement in this content?

Annovis Bio Inc. (NYSE: ANVS) announced that CEO Maria Maccecchini, Ph.D., will present at the H.C. Wainwright 27th Annual Global Investment Conference taking place September 8-10, 2025, at the Lotte New York Palace Hotel in New York City.

Who is presenting for Annovis Bio at the conference?

Maria Maccecchini, Ph.D., the CEO of Annovis Bio Inc., will be presenting on behalf of the company at the H.C. Wainwright Global Investment Conference.

When and where is the H.C. Wainwright conference taking place?

The conference is scheduled for September 8-10, 2025, and will be held at the Lotte New York Palace Hotel in New York City.

What is Annovis Bio’s focus and mission?

Annovis Bio is dedicated to addressing neurodegeneration in diseases such as Alzheimer’s Disease (AD) and Parkinson’s Disease (PD), developing innovative therapies that improve patient outcomes and quality of life. The company is headquartered in Malvern, Pennsylvania.

Where can I find more information about Annovis Bio?

More information is available at www.annovisbio.com, and you can follow the company on LinkedIn, YouTube, and X. The latest news and updates are also available in the company’s newsroom at https://ibn.fm/ANVS.

Where can I view the full press release about this announcement?

The full press release can be viewed at https://ibn.fm/bX1aJ, which provides complete details about Annovis Bio’s participation in the H.C. Wainwright conference.

InvestorWire is a specialized communications platform that provides advanced wire-grade press release syndication services. It is part of the Dynamic Brand Portfolio at IBN and helped distribute this announcement through various channels including syndication to 5,000+ outlets and social media distribution.